Neuros Medical, Inc., a medical device company, announced promising results today from their recently completed feasibility study. The study was the first human test of the Company's patented high frequency Electrical Nerve Block™ technology and focused on patients with chronic amputation pain which affects nearly one million patients in the U.S. During the study, four of the five patients reported their pain was reduced to zero.
Study participant Darren W. said, "My pain was gone, something I have not experienced since my amputation. I was able to sleep completely through the night, my first pain-free sleep in several years." Participant Claude G. also experienced considerable pain relief and said, "The reduction of my pain was amazing, provided a feeling of freedom, and allowed me to work in my woodworking shop for hours."
The study was led by Dr. Amol Soin of the Kettering Health Network Innovation Center and the Ohio Pain Clinic. "Providing such significant pain relief for the patients is outstanding," said Dr. Soin. "A complete reduction is often unheard of, however the high frequency electrical nerve block technology showed the ability to do so, safely and consistently, and the strong potential it holds for patients suffering from chronic pain is very encouraging," he added.
Jon J. Snyder, President and CEO of Neuros Medical, said, "We are obviously very pleased with the results in reducing the patients' pain scores so significantly. These impactful outcomes indicate a very bright future for the technology as a potential treatment for chronic pain. We look forward to sharing more details at the upcoming International Neuromodulation Society 10th World Congress in London this coming May."
Ozempic effective for patients with chronic kidney damage